Can morning light boost melanoma treatment? new trial tests simple iPad therapy
NCT ID NCT07628894
First seen Jun 07, 2026 · Last updated Jun 23, 2026 · Updated 5 times
Summary
This early-phase trial tests whether a home-based morning light therapy program can help people with advanced melanoma who are receiving tumor-infiltrating lymphocyte (TIL) therapy. The light therapy is delivered through an iPad app and aims to improve the body's natural sleep-wake cycle, which may be disrupted by cancer and hospital stays. The study will enroll 8 participants and focus on whether the light therapy is safe and easy to follow.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Contact Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Circadian-Optimized Light Therapy (COLT) via iPad app
What this could lead to
If it works, this could point toward a simple way to boost the effectiveness of TIL therapy for advanced melanoma by improving patients' sleep-wake cycles.
What could go wrong
This is a very early, small pilot study with only 8 participants. It is designed mainly to test if the light therapy is safe and doable, not whether it actually helps. The results may not apply to other patients or settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.